WeVote
Log In

Bill

Bill

HD 1228

An Act establishing Medicare for All in Massachusetts

194th Legislature (2025-2026) Introduced by James Arena-DeRosa and 27 co-sponsors

Massachusetts bill proposes replacing multi-payer insurance with single-payer state healthcare system funded through taxes, requiring federal waivers and substantial tax increases.

0
WeVote Research Nonpartisan
Bill Summary · HD 1228

Legislative bill overview

HD 1228 proposes establishing a single-payer healthcare system in Massachusetts where the state government would provide comprehensive health coverage to all residents, replacing the current multi-payer private insurance system. The bill would create a unified state healthcare program funded through taxes rather than individual premiums, copayments, and deductibles.

Why is this important

Massachusetts currently has the highest health insurance coverage rate in the nation (~97%), but residents still face high out-of-pocket costs and medical debt. A single-payer system would fundamentally reshape how healthcare is financed and delivered, potentially reducing administrative costs but requiring significant tax increases and federal waivers to modify existing Medicare/Medicaid programs.

Potential points of contention

  • Financing mechanism: Requires substantial new state taxes (likely payroll or income-based) to replace current premium payments; total cost estimates and tax rates would be politically contentious
  • Federal authority conflicts: Requires federal waivers to modify Medicare and Medicaid, which Massachusetts cannot unilaterally control, creating implementation uncertainty
  • Healthcare provider impacts: Negotiated payment rates could affect hospital revenues and physician compensation, raising concerns from medical industry stakeholders about service reductions or provider exodus
  • Employer and employee transitions: Eliminates employer-sponsored insurance, disrupting existing coverage arrangements and raising questions about transition costs and timeline
  • Impact on healthcare innovation: Critics argue reduced profit incentives may slow drug development and medical technology advancement

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.